Cofco Biotechnology Co (SZSE:000930) COGS-to-Revenue : 0.93 (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Cofco Biotechnology Co COGS-to-Revenue?

Cofco Biotechnology Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥4,387 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥4,732 Mil.

Cofco Biotechnology Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.93.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Cofco Biotechnology Co's Gross Margin % for the three months ended in Mar. 2024 was 7.29%.

Cofco Biotechnology Co COGS-to-Revenue Historical Data

The historical data trend for Cofco Biotechnology Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cofco Biotechnology Co COGS-to-Revenue Chart

Cofco Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.86

0.90

0.89

0.94

Cofco Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.94	0.96	0.93	0.95	0.93

Cofco Biotechnology Co COGS-to-Revenue Calculation

Cofco Biotechnology Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	19255.712	/	20378.95
	=	0.94

Cofco Biotechnology Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4386.677	/	4731.528
	=	0.93

Cofco Biotechnology Co (SZSE:000930) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Cofco Biotechnology Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4386.677 / 4731.528
	=	7.29 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cofco Biotechnology Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cofco Biotechnology Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cofco Biotechnology Co (SZSE:000930) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cofco Biotechnology Co Ltd (SZSE:000930) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Jianguomen Nei Avenue, 7th Floor, Tower A, COFCO Plaza, Dongcheng District, Beijing, CHN, 100005

Website

http://www.zlahsh.com

Cofco Biotechnology Co Ltd is an agricultural product processing enterprises in China. Its products include fuel ethanol, citric acid, L-lactic acid, ethylene oxide, amino acids, fats, fruit juice, and gluten meal, Fuel ethanol, organic fertilizer and others.

Executives

Zhang De Guo	Directors, executives
Wang Yu	Executives
Pan Xi Chun	Secretary Dong
Tong Yi	Director
Sun Deng Bao	Executives
Li Bei	Directors, executives
Xia Ling He	Director
Zou Pei Jun	Executives
Wang De Wen	Executives
Yue Guo Jun	Director
Shi Gong Zhi	Executives
Cai Qi Hai	Executives

Cofco Biotechnology Co (SZSE:000930) Headlines

No Headlines